Sage Therapeutics Inc. sued Biogen Inc. on Friday, a week after the biotech giant made an unsolicited offer to acquire the ...

Intellia Therapeutics announced its strategic priorities and key anticipated milestones for 2025. However, investors were ...

As I ran from interview to interview across San Francisco, I was consistently warmed by the stories I was told by biotech and ...

Sage Therapeutics (NASDAQ:SAGE) is reportedly suing Biogen (NASDAQ:BIIB) over enforcement of a standstill agreement in the ...

Sage Therapeutics has sued Biogen in Delaware court, one week after receiving a $469 million buyout offer from the larger ...